Nucleate Vanderbilt
Biotechnology Research • 
401 21st Ave S, Nashville, United States • 1-10 Employees
Company overview
| Headquarters | 401 21st Ave S, Nashville, TN, US |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
Key Contact at Nucleate Vanderbilt
Charlotte Cruickshank
Vice President of External Affairs and Events
About Nucleate Vanderbilt
Nashville's budding hub for biotechnology and life sciences education and innovation. Currently launching Nucleate Dojo's inaugural Nashville cohort, a selective 6-week seminar style program for students to learn the ins and outs of successful venture creation in the life sciences, and connect with leaders in biotech.
$
Nucleate Vanderbilt revenue & valuation
| Annual revenue | $855,550 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Vice President
Employees by Department
Nucleate Vanderbilt has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Nucleate Vanderbilt has never raised funding before.
Australia
Italy
France
IrelandFrequently asked questions
Nucleate Vanderbilt is located in 401 21st Ave S, Nashville, US.
Nucleate Vanderbilt was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.
Nucleate Vanderbilt has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
